Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7303
Reference
MSAN(2021)17
Name
Voriconazole (VFEND®) 40mg/ml powder for oral suspension
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Voriconazole 40mg/ml powder for oral suspension is out of stock until late April 2021.
2. Patients in primary care with insufficient supply who need continued treatment, should be referred back to secondary care for review.
3. Health Boards with residual stock should reserve supplies for children 2 to <12 years of age or patients who require administration via enteral feeding tubes.
4. Voriconazole 50mg, 100mg and 200mg tablets remain available.
5. Unlicensed supplies of voriconazole 40mg/ml oral suspension can be sourced.
2. Patients in primary care with insufficient supply who need continued treatment, should be referred back to secondary care for review.
3. Health Boards with residual stock should reserve supplies for children 2 to <12 years of age or patients who require administration via enteral feeding tubes.
4. Voriconazole 50mg, 100mg and 200mg tablets remain available.
5. Unlicensed supplies of voriconazole 40mg/ml oral suspension can be sourced.
Contact Name
Contact Email
Contact Address
Created
2021-04-15 00:00:00
Click to go back to homepage